Co-Authors
This is a "connection" page, showing publications co-authored by Jérémie Guedj and Gilles Peytavin.
Connection Strength
0.283
-
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. J Antimicrob Chemother. 2020 09 01; 75(9):2376-2380.
Score: 0.225
-
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. J Antimicrob Chemother. 2021 01 01; 76(1):277-279.
Score: 0.058